Article
Clinical Significance of the NQO1 C609T Polymorphism in Non Small Cell Lung Adenocarcinoma Patients.
Asian Pacific journal of cancer prevention : APJCP - 1 Jan 2015
Masroor Mirza, Jain Amit, Javid Jamsheed, Mir Rashid, Prashant Y, Imtiyaz A, Mariyam Z, Mohan Anant, Ray P C, Saxena Alpana
Abstract excerpt
BACKGROUND: NAD(P)H: quinone oxidoreductase 1 (NQO1) is part of the antioxidant defence system involved in detoxification. This study aimed to analyze the influence of NQO1 (C609T) genetic polymorphism in non small cell lung cancer (NSCLC)as a putative risk factor. MATERIALS AND METHODS: Present study included 100 cases of NSCLC (adenocarcinoma) patients and 100 age and sex matched healthy controls. NQO1 (C609T)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
